Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $1.7 million.

  • Ekso Bionics Holdings' Current Deferred Revenue fell 1662.58% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 1662.58%. This contributed to the annual value of $2.0 million for FY2024, which is 185.65% down from last year.
  • Ekso Bionics Holdings' Current Deferred Revenue amounted to $1.7 million in Q3 2025, which was down 1662.58% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Current Deferred Revenue ranged from a high of $3.1 million in Q1 2021 and a low of $1.1 million during Q4 2022
  • Over the past 5 years, Ekso Bionics Holdings' median Current Deferred Revenue value was $2.0 million (recorded in 2024), while the average stood at $2.1 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first crashed by 5840.45% in 2022, then soared by 7778.77% in 2023.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Current Deferred Revenue stood at $2.7 million in 2021, then tumbled by 58.4% to $1.1 million in 2022, then surged by 77.79% to $2.0 million in 2023, then fell by 1.86% to $2.0 million in 2024, then fell by 13.09% to $1.7 million in 2025.
  • Its Current Deferred Revenue was $1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.9 million in Q1 2025.